-
Interpol seized $41 mn fake drugs to be sold online
biospectrumasia
October 12, 2018
Interpol seized $41 mn fake drugs to be sold online
-
Big Pharma's antibody drugs for asthma show benefits but cost 50% too much: ICER
fiercepharma
September 28, 2018
New antibody-based treatments are better than traditional drugs for moderate to severe asthma, but they still cost too much, a U.S. drug cost watchdog says. More than 50% too much, in fact.
-
AstraZeneca plots China robot offensive to counter price cuts
expressbpd
September 21, 2018
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to becoming a broad healthcare provider in China
-
AstraZeneca to increase presence in China
pharmafile
September 20, 2018
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to expand the overall market...
-
FDA steps up action to ensure quality of compound drugs
europeanpharmaceuticalreview
September 18, 2018
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them…
-
New US legislation aims to expedite development of non-opioid pain drugs
pharmaphorum
September 12, 2018
The US Senate looks set to pass a set of laws designed to tackle the country’s opioid crisis, encouraging research into non-addictive painkillers, as well as preventing opioids entering the country from China through the mail.
-
Pharm D Solutions Issues Voluntary Recall of all Sterile Compounded Drugs
americanpharmaceuticalreview
September 12, 2018
Pharm D Solutions is voluntarily recalling all sterile compounded drug products within expiry to the clinic, physician or consumer level. These drug products are being voluntarily recalled due to concerns that practices at the pharmacy have the potential
-
Russian Institute for Drugs and Good Practices unveils new data guide
europeanpharmaceuticalreview
September 11, 2018
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group…
-
FDA approves magnetic brain-zapping helmet to treat OCD sufferers who don't respond to therapy or drugs
dailymail
September 04, 2018
A brain 'zapping' device was approved to treat obsessive compulsive disorder by the US Food and Drug Administration (FDA).
-
Statement from FDA Commissioner to Improve Access to OTC Drugs
americanpharmaceuticalreview
July 24, 2018
At the FDA, we’re continuing to look at ways we can foster greater access to the medicines that help keep people healthy.